课题基金 / 基金详情

CLINICAL TRIAL: TONIC - TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN

CLINICAL TRIAL: TONIC - TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN
临床试验:补品 - 治疗儿童非酒精性脂肪性肝炎
批准号:
7950942
负责人:
JOEL Edward LAVINE
金额:
$15.85万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30

项目摘要

项目成果

JOEL Edward LAVINE的其他基金

相似基金

相关文献

中文摘要
翻译
该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金, 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说,它不一定是研究者的机构。 评估与安慰剂治疗相比,二甲双胍或维生素 E 治疗 96 周是否会导致患有 NAFLD 的非糖尿病儿童血清 ALT 持续降低。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Evaluate whether 96 weeks of treatment with either metformin or vitamin E leads to sustained reduction in serum ALT in nondiabetic children with NAFLD compared to treatment with placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
XENOBIOTIC BIOTRANSFORMATION IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE
CLINICAL TRIAL: TONIC - TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN
CLINICAL TRIAL: PIOGLITAZONE VS VITAMIN E VS PLACEBO FOR NONALCOHOLIC STEATOHEPA
CLINICAL TRIAL: NON-ALCOHOLIC STEATOHEPATITIS CLINICAL RESEARCH NETWORK
海外基金